Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Assets Average (2016 - 2025)

Historic Assets Average for Sunshine Biopharma (SBFM) over the last 13 years, with Q3 2025 value amounting to $31.7 million.

  • Sunshine Biopharma's Assets Average rose 689.86% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 689.86%. This contributed to the annual value of $29.0 million for FY2024, which is 232.64% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Assets Average of $31.7 million as of Q3 2025, which was up 689.86% from $30.6 million recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Assets Average high stood at $41.4 million for Q3 2022, and its period low was $1.5 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $28.1 million (2023), whereas its average is $23.3 million.
  • Per our database at Business Quant, Sunshine Biopharma's Assets Average soared by 181839.86% in 2022 and then tumbled by 3233.95% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Assets Average (Quarter) stood at $2.4 million in 2021, then soared by 1390.14% to $35.1 million in 2022, then fell by 21.55% to $27.5 million in 2023, then grew by 10.22% to $30.3 million in 2024, then rose by 4.68% to $31.7 million in 2025.
  • Its last three reported values are $31.7 million in Q3 2025, $30.6 million for Q2 2025, and $29.9 million during Q1 2025.